"Laboratorium en kliniek voor geneesmiddelenonderzoek"

During the past decade, QPS Netherlands B.V. conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 4 clinical trials were completed, i.e. on average, 16% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "QPS Netherlands B.V." #1 sponsor was "Coloplast A/S" with 6 trials, followed by "Idorsia Pharmaceuticals Ltd." with 6 trials sponsored, "Alkermes, Inc." with 2 trials sponsored, "H. Lundbeck A/S" with 2 trials sponsored and "Annexin Pharmaceuticals AB" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "QPS Netherlands B.V." #1 collaborator was "QPS Netherlands B.V." with 4 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "QPS Holdings LLC" with 1 trials as a collaborator, "QPS-Qualitix" with 1 trials as a collaborator and "University Medical Center Groningen" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "QPS Netherlands B.V." are "Healthy" (9 trials), "Colostomy" (3 trials), "Healthy Subjects" (3 trials), "Ileostomy - Stoma" (3 trials) and "Ileostomy" (2 trials). Many other conditions were trialed in "QPS Netherlands B.V." in a lesser frequency.

Most popular intervention types in "QPS Netherlands B.V." are "Drug" (17 trials), "Device" (6 trials), "Other" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Clazosentan" (2 trials), "Moxifloxacin" (2 trials), "Rifampicin" (2 trials) and "14C-ACT-777991 microtracer (MAD - ADME)" (1 trials). Other intervention names were less common.

The vast majority of trials in "QPS Netherlands B.V." are 17 trials for "All" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "QPS Netherlands B.V.". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in QPS Netherlands B.V., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in QPS Netherlands B.V., 20 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".